The company has informed NICE that it will be withdrawing their evidence submission for this appraisal.
Therefore, we are suspending the appraisal while we consider the next steps
Status | Suspended |
Decision | Selected |
Process | STA 2018 |
ID number | 1440 |
Project Team
Project lead | Shonagh D'Sylva |
Email enquiries
- If you have any queries please email TAteam2@nice.org.uk
External Assessment Group | Health Economics Research Unit and Health Services Research Unit, University of Aberdeen |
Stakeholders
Companies sponsors | Medtronic (TYRX Absorbable Antibacterial Envelope) |
Others | Department of Health and Social Care |
NHS England | |
Welsh Government | |
Patient carer groups | A F Association |
Professional groups | British Cardiovascular Society |
British Society for Antimicrobial Chemotherapy | |
Royal College of Physicians | |
UK Clinical Pharmacy Association | |
Associated public health groups | none |
Comparator companies | none |
General commentators | All Wales Therapeutics and Toxicology Centre |
British National Formulary | |
Department of Health, Social Services and Public Safety for Northern Ireland | |
Healthcare Improvement Scotland | |
Welsh Health Specialised Services Committee | |
Relevant research groups | none |
Timeline
Key events during the development of the guidance:
Date | Update |
---|---|
07 February 2022 | Suspended. The company has informed NICE that it will be withdrawing their evidence submission for this appraisal. Therefore, we are suspending the appraisal while we consider the next steps |
19 August 2021 | Following the appraisal committee meeting on Wednesday Thursday 4 August 2021, NICE has decided to pause this appraisal to allow the company to continue commercial discussions. |
04 August 2021 | Committee meeting: 1 |
04 May 2021 | Please note that due to operational reasons the committee meeting (scheduled 9 June 2021) has been delayed. The committee meeting has now been scheduled to 4 August 2021. |
05 May 2020 | Schedule affected by COVID-19. Topic update: this appraisal has not been defined as therapeutically critical. The appraisal will therefore be paused. At this stage, we are unable to provide alternative timelines as to when the appraisal may be re-started but we will provide an update when this information is available. |
12 November 2019 | The Technology appraisal (ID1440) for TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices has been suspended. Medtronic have offered a Patient Access Scheme, however, NHS England recently provided feedback that this proposal could not be operationalised. Consequently Medtronic requested NICE to suspend the Technology Appraisal while other options are explored. |
29 March 2019 | Invitation to participate |
29 March 2019 | In progress. The invitation to participate went out to the stakeholders. |
13 September 2018 (10:00) | Scoping workshop (London) |
23 July 2018 - 20 August 2018 | Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators |
For further information on our processes and methods, please see our CHTE processes and methods manual